BioFocus DPI announced today that Scott Snyder has joined as Senior Director of Compound Management at BioFocus DPI’s compound management facility in South San Francisco, CA, USA. Mr. Snyder has over fifteen years of experience working within the life sciences sector. He was previously with BioProcessors Corporation where he was Director, Commercial Development. Prior to that, Mr. Snyder was Associate Director of Sample Management and Screening at The Automation Partnership.

Dr. Chris Newton, Senior VP BioFocus DPI, commented, “Through his experience in automation and sample management and strong commercial background, Scott is ideally suited to lead BioFocus DPI’s compound management activities. His appointment is designed to take what is already a successful business to new heights and occurs at a time when we recently signed a large deal with Dart Neuroscience, which itself encompasses a significant compound management component.”

About BioFocus DPI

BioFocus DPI aims to expand its partners’ drug pipelines by accelerating the gene-to-candidate discovery process. This is achieved through a comprehensive discovery platform, which includes target discovery in human primary cells, focused as well as diverse compound libraries, in vitro and cell-based screening, structural biology, medicinal chemistry, ADME/PK services, supported by unique chemogenomic and informatics tools, and compound library acquisition, storage and distribution services. As the service division of Galapagos, BioFocus DPI has over 250 employees in four countries worldwide.